Tyramine in Malt Beverages Interfering with Monoamine Oxidase Inhibitor Drugs

  • Sadeghi N
  • Oveisi M
  • Jannat B
  • et al.
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The objective of this review is the determination of tyramine in 13 nonalcoholic beers (Maoshaieer) of Tehran market and survey of it’s probably interaction with monoamine oxidase inhibitor drugs (MAOIs) has been investigated. Tyramine was at the highest levels in Baltika (111.34 ± 8.19 µg/ml) and at the lowest level in Bitmalt (8.01 ± 2.09 µg/ml). Comparing different flavors of malt drinks, the highest tyramine content was shown for classic or normal flavor (average 72.99 ± 30.87 µg/ml), while the lowest value belonged to cantaloupe flavored drinks (average 10.55 ± 1.29 µg/ml). In our study, it is seen that there is a significant difference between import and Iranian non-alcoholic beers, the import ones has more tyramine than Iranians. A number of 10 kinds of 13 samples interact whit MAOIs in one serving (250 ml) usage 18.50 mg. The highest tyramine content of Iranian ones is 17.74 mg/250ml and for import ones is 27.83 mg/250ml.

Cite

CITATION STYLE

APA

Sadeghi, N., Oveisi, M. R., Jannat, B., Behzad, M., Hajimahmoodi, M., & Zareakram, E. (2016). Tyramine in Malt Beverages Interfering with Monoamine Oxidase Inhibitor Drugs. Journal of Biosciences and Medicines, 04(08), 10–16. https://doi.org/10.4236/jbm.2016.48002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free